Variable | Subtype | Hazard Ratio (95% conf. interval) | p-value | |
---|---|---|---|---|
Univariate | Resection type* | PALN- | 0.57(0.31–1.05) | 0.05 |
EXP | 2.31(1.30–4.11) | < 0.001 | ||
Demographic | Female sex | 0.80(0.67–0.97) | 0.02 | |
Age | 1.01(1.00-1.03) | < 0.001 | ||
Charlson Comorbidity Index | 1.06(1.01–1.10) | < 0.001 | ||
Oncology treatment | Preoperative chemotherapy | 0.54(0.43–0.70) | < 0.001 | |
Postoperative Chemotherapy | 0.42(0.34–0.51) | < 0.001 | ||
Multivariate | Resection type* | PALN- | 0.50(0.27–0.93) | 0.03 |
EXP | 2.36(1.32–4.20) | < 0.001 | ||
Demographic | Female sex | 0.85(0.71–1.03) | 0.10 | |
Age | 1.01(0.99–1.01) | 0.39 | ||
Charlson Comorbidity Index | 1.03(0.99–1.07) | 0.17 | ||
Oncology treatment | Preoperative chemotherapy | 0.43(0.33–0.55) | < 0.001 | |
Postoperative Chemotherapy | 0.39(0.32–0.49) | < 0.001 |